ACCESSION: MSBNK-SMB_Measured-HSA001P0114029
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'10_posi_2272': {'bp': 3408948.0, 'sum': 7594267.0}, '9_posi_2649': {'bp': 1305618.0, 'sum': 3375323.0}, '13_posi_2665': {'bp': 1038460.0, 'sum': 3226451.0}, '16_posi_2244': {'bp': 1472764.0, 'sum': 4609316.0}, '11_posi_2627': {'bp': 1749877.0, 'sum': 4035442.0}, '9_posi_2262': {'bp': 1726203.0, 'sum': 5354501.0}, '15_posi_2293': {'bp': 2420504.0, 'sum': 5661602.0}, '12_posi_2246': {'bp': 1607509.0, 'sum': 5188938.0}, '15_posi_2670': {'bp': 1250428.0, 'sum': 3706584.0}, '8_posi_2242': {'bp': 1589084.0, 'sum': 5061919.0}, '2_posi_2586': {'bp': 1391443.0, 'sum': 4067025.0}, '12_posi_2704': {'bp': 780633.0, 'sum': 2414015.0}, '14_posi_2648': {'bp': 1492938.0, 'sum': 3490858.0}, '6_posi_2626': {'bp': 2089308.0, 'sum': 4566861.0}, '7_posi_2263': {'bp': 1731361.0, 'sum': 5305631.0}, '10_posi_2647': {'bp': 1302748.0, 'sum': 3656483.0}, '2_posi_2203': {'bp': 1592760.0, 'sum': 4805581.0}, '4_posi_2644': {'bp': 874778.0, 'sum': 2926177.0}, '19_posi_2431': {'bp': 1641302.0, 'sum': 5297854.0}, '19_posi_2816': {'bp': 854402.0, 'sum': 2512533.0}, '17_posi_2726': {'bp': 829667.0, 'sum': 2713694.0}, '5_posi_2684': {'bp': 676805.0, 'sum': 2117935.0}, '16_posi_2708': {'bp': 893278.0, 'sum': 2867666.0}, '13_posi_2264': {'bp': 2242747.0, 'sum': 5927815.0}}
COMMENT: RETENTION_TIME_STDEV 0.418
COMMENT: PRECURSOR_M/Z_RAW 114.066243
COMMENT: PRECURSOR_M/Z_STDEV 0.000032
COMMENT: PRECURSOR_IN_MS1 mz 114.066226; int 355.466; delta(ppm) 1.446246
COMMENT: PROPOSED_CHARGE_STATE +1; mz 115.069535; int 14.780; cor 0.930
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.318; C4H7N3O; [M+H]+; delta(ppm) 0.318418
COMMENT: PROPOSED_MF MS-FINDER 3.537; C4H7N3O; [M+H]+; delta(ppm) 0.312981
COMMENT: PROPOSED_MF SIRIUS5_Sirius 22.587; C4H7N3O; [M+H]+; delta(ppm) 0.312981
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H7N3O; [M+H]+; delta(ppm) 0.312981
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.942; C4H7N3O; [M+H]+; delta(ppm) 0.312981
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.025; C6H9O2; [M+H]+; delta(ppm) -11.457800
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.563; C2H5N6; [M+H]+; delta(ppm) 12.084040
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H7N3O; [M+H]+; delta(ppm) 0.312981
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.746; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; CN1C=C(O)N=C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.600; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; CN1CC(=O)NC1=N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.554; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; C1C=CNN1C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.167; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; CN(CCC#N)N=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.984; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; Creatinine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.447; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; 1,3-dihydropyrazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.389; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; 2-amino-1-methyl-imidazol-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.169; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; 3-(N-Nitrosomethylamino)propionitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; 1,3-dihydropyrazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.870; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; Creatinine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.766; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; 2-amino-1-methyl-imidazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.620; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; 3-(N-Nitrosomethylamino)propionitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.913; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methyl-4H-imidazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.222; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; N-(2-cyanoethyl)-N-methylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; FOOFYKFJNMAAQE-UHFFFAOYSA-N; [M+H]+; N-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.041; KXLLKSHFFVQKTQ-UHFFFAOYSA-N; [M+H]+; 2-cyanoethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; HGPUJQWMCPURNO-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.943; XGKOIOPVLYCTRF-UHFFFAOYSA-N; [M+H]+; 5-amino-2-methyl-4H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; YGVFIVSNVVUSCS-UHFFFAOYSA-N; [M+H]+; 5-amino-2-methyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.911; BVNFZLFQKJYVDJ-UHFFFAOYSA-N; [M+H]+; 3,4-dimethyl-1H-1,2,4-triazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.909; IRPLFUJJHBGEAL-UHFFFAOYSA-N; [M+H]+; 3-amino-2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.909; MKSFCAQPDWJPND-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.909; AUZHYHBJZVEQNI-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.907; VUYWQWFWWHLKFG-UHFFFAOYSA-N; [M+H]+; 4-amino-5-methyl-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; NZORXPUYHVZTQG-UHFFFAOYSA-N; [M+H]+; (3-amino-1H-pyrazol-5-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.891; XHSTYRIUVMKGDX-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; MTHUPGKUEISSDE-UHFFFAOYSA-N; [M+H]+; 2-amino-N-(cyanomethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; LFSXUCZAZSQBPW-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.860; HUSLEZCKWCUICB-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.835; HJEVQOSZWIDFQJ-UHFFFAOYSA-N; [M+H]+; 2-(2H-triazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; PKHVUMMJMYKRNO-UHFFFAOYSA-N; [M+H]+; 2-(triazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.831; DLLDJWMWMVUIDZ-UHFFFAOYSA-N; [M+H]+; (3-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.831; XKKMMJLWDOKNEW-UHFFFAOYSA-N; [M+H]+; (1-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.825; XJUQLFVCCWNFJJ-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.808; CIFUFRVSHZKBEO-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.808; YOSYLAYVXLOORB-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-triazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.797; KNIARYZRPMJYFH-UHFFFAOYSA-N; [M+H]+; 2-(1H-1,2,4-triazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.795; WYZRLXYOIMXEBO-UHFFFAOYSA-N; [M+H]+; 1-(1H-1,2,4-triazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.774; CLVALLQETQTQMV-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-triazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.771; QUAQZVSGXQVIEP-UHFFFAOYSA-N; [M+H]+; (2-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.767; RTCYUGLJCAPLPD-UHFFFAOYSA-N; [M+H]+; (2-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.754; WEDYTSQNYJKOPC-UHFFFAOYSA-N; [M+H]+; (1-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.684; PFBCKBGKRFYNLE-UHFFFAOYSA-N; [M+H]+; (5-methyl-2H-triazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.678; HKIXGXYGOILGSX-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.678; CIHQZPVUYBHNQO-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.654; YWXPPKJKSSLZOD-UHFFFAOYSA-N; [M+H]+; 5-(methoxymethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.653; DSFUCCQCXNNWLA-UHFFFAOYSA-N; [M+H]+; 3-methoxy-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.647; BMTFHVKZYIOHBE-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.643; YUTNQQHHUYYBFA-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.624; OTERRMWTPZGJLB-UHFFFAOYSA-N; [M+H]+; 4-ethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.619; YKTPXKSUWIQBML-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,2,5-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.605; NPBUMVMXXGQOEG-UHFFFAOYSA-N; [M+H]+; (3-methyl-1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.605; KPBSGOLXLCARIL-UHFFFAOYSA-N; [M+H]+; (5-methyl-1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.588; HNXYWYOVPHLAQF-UHFFFAOYSA-N; [M+H]+; N,4-dimethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.244; GZDJNVITGJORKZ-UHFFFAOYSA-N; [M+H]+; ethyl N'-cyanocarbamimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.235; LODVFGWSULLZAU-UHFFFAOYSA-N; [M+H]+; 4-methoxy-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.233; OMFADAFZDYXVOK-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -136.262; CMIPWACBRYWGPN; [M+H]+; 1-Cyano-2,3-dimethylisourea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.464; KXLLKSHFFVQKTQ; [M+H]+; 2-Cyanoethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.955; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.051; HZDLDFBKYBGNHG; [M+H]+; 3-Methylnitrosaminopropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.300; OMFADAFZDYXVOK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.992; HGPUJQWMCPURNO; [M+H]+; Ambcb4035725
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.076; XHSTYRIUVMKGDX; [M+H]+; 2-NH2-5-ET-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.388; OTERRMWTPZGJLB; [M+H]+; 4-ethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -293.250; CLVALLQETQTQMV; [M+H]+; triazolylethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -302.365; RTCYUGLJCAPLPD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -302.823; DLLDJWMWMVUIDZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -340.286; IRPLFUJJHBGEAL; [M+H]+; 5-amino-1-methyl-1H-pyrazol-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -360.879; PKHVUMMJMYKRNO; [M+H]+; 2-(1-triazolyl)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -386.732; MKSFCAQPDWJPND; [M+H]+; Azamuscimol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.442; CMIPWACBRYWGPN; [M+H]+; 1-Cyano-2,3-dimethylisourea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -64.489; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -99.884; PPVUWDCETZMPLT; [M+H]+; 5-Dihydro-1h-pyrazole-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -118.078; CMIPWACBRYWGPN; [M+H]+; 1-Cyano-2,3-dimethylisourea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.901; XGKOIOPVLYCTRF; [M+H]+; 3-amino-1-methyl-4,5-dihydro-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -122.279; KXLLKSHFFVQKTQ; [M+H]+; 2-Cyanoethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -128.297; HZDLDFBKYBGNHG; [M+H]+; 3-(Methyl-D3-nitrosoamino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -146.112; FOOFYKFJNMAAQE; [M+H]+; N-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -154.806; XHSTYRIUVMKGDX; [M+H]+; 5-Ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -155.111; BVNFZLFQKJYVDJ; [M+H]+; 3H-1,2,4-Triazol-3-one, 2,4-dihydro-4,5-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -189.010; CLVALLQETQTQMV; [M+H]+; 1H-1,2,4-Triazole-1-ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.397; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H8N3O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 5.022
MS$FOCUSED_ION: PRECURSOR_M/Z 114.066224
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-4900000000-8a3c676dfca4ab627de2
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0699261 3.9361 69.070551 1.8966 1.76 0.0421 20 ?
  70.0651384 5.9016 70.065758 1.1561 2.89 0.1965 19 f{C4H8N1}/0.18ppm,p-N2O1
  71.0603764 893.4749 71.060990 0.2533 202.70 0.6861 24 f{C3H7N2}/0.02ppm,p-C1H1N1O1
  72.0443743 9.1931 72.044981 1.1104 1.49 0.9304 24 f{C3H6N1O1}/-0.22ppm,p-C1H2N2
  79.0542171 5.9167 79.054764 1.2903 2.90 -0.0896 24 ?
  85.0760938 5.7348 85.076573 1.2107 2.47 0.4308 23 ?
  86.0601824 7.5432 86.060649 1.6965 2.90 0.5632 23 f{C4H8N1O1}/1.65ppm,p-N2
  86.0712677 81.1457 86.071734 0.2556 9.26 0.9861 24 f{C3H8N3}/-0.07ppm,p-C1O1
  96.0807949 5.6950 96.081147 1.4987 2.30 0.2603 22 ?
  97.0760033 6.0558 97.076348 1.4937 2.57 0.5168 23 ?
  104.0818770 21.6948 104.082163 1.1914 2.62 0.9348 24 ?
  114.0662502 999.0000 114.066433 0.2981 91.14 1.0000 24 f{C4H8N3O1}/0.54ppm,p
  114.0913863 147.9535 114.091568 0.5522 59.06 0.0078 24 ?
  114.1025036 832.6155 114.102685 0.5083 185.72 0.6713 24 ?
PK$NUM_PEAK: 14
PK$PEAK: m/z int. rel.int.
  69.069926 3.94 3
  70.065138 5.90 5
  71.060376 893.47 893
  72.044374 9.19 9
  79.054217 5.92 5
  85.076094 5.73 5
  86.060182 7.54 7
  86.071268 81.15 81
  96.080795 5.70 5
  97.076003 6.06 6
  104.081877 21.69 21
  114.066250 999.00 999
  114.091386 147.95 147
  114.102504 832.62 832
//
